Author:
Tian Guo-Bao,Adams-Haduch Jennifer M.,Taracila Magdalena,Bonomo Robert A.,Wang Hong-Ning,Doi Yohei
Abstract
ABSTRACTADC-56, a novel extended-spectrum AmpC (ESAC) β-lactamase, was identified in anAcinetobacter baumanniiclinical isolate. ADC-56 possessed an R148Q change compared with its putative progenitor, ADC-30, which enabled it to hydrolyze cefepime. Molecular modeling suggested that R148 interacted with Q267, E272, and I291 through a hydrogen bond network which constrained the H-10 helix. This permitted cefepime to undergo conformational changes in the active site, with the carboxyl interacting with R340, likely allowing for better binding and turnover.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献